<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496286/" ref="ordinalpos=2017&amp;ncbi_uid=5026415&amp;link_uid=PMC3496286" image-link="/pmc/articles/PMC3496286/figure/F1/" class="imagepopup">Figure 1. Generalized Schematic of Conventional and Biased Cardiac β1-AR <span class="highlight" style="background-color:">Signaling</span>.  From: Conducting the G-protein Coupled Receptor (GPCR) <span class="highlight" style="background-color:">Signaling</span> Symphony in Cardiovascular Diseases: New Therapeutic Approaches. </a></div><br /><div class="p4l_captionBody">Epinephrine and norepinephrine enhance myocardial contractility, heart rate, and apoptosis through Gαs-coupled signaling pathways in heart (black arrows). Furthermore, these catecholamines can activate an anti-apoptotic cascade independent of Gαs (green arrows). Putative biased ligands induce cardioprotection by exclusively promoting the G protein coupled receptor kinase (GRK) and β-arrestin-mediated pathway (green arrows).</div></div>